Low expression of MLKL protein is associated with decreased overall survival (OS) in patients with pancreatic adenocarcinoma30, colon cancer31, ovarian cancer32 and NSCLC33, probably due to insufficient MLKL necroptosis signaling, suggesting that necroptosis is an important determinant of cancer cell death and outcomes in these patients. This evidence concerns the gene MLKL and cancer.